Showing results (641-650 of 711) with videos related to
Sort By:
Pageof 72
Surgery|May 1, 1990
The hepatotropic influence of cyclosporineV Mazzaferro, K A Porter, C L Scotti-Foglieni, et al.The Journal of Laboratory and Clinical Medicine|November 1, 1988
Does hyperprolactinemia affect hepatic regeneration independent of sex steroids?D Kahn, J S Gavaler, L Makowka, et al.Transplantation|January 1, 1991
The liver transplant waiting list--a single-center analysisR D Gordon, C M Hartner, A Casavilla, et al.Annals of Surgery|September 1, 1991
Hepatic resection versus transplantation for hepatocellular carcinomaS Iwatsuki, T E Starzl, D G Sheahan, et al.The Journal of Pharmacy and Pharmacology|August 1, 1991
In-vitro interaction of a novel immunosuppressant, FK 506, and antacidsM Steeves, H Y Abdallah, R Venkataramanan, et al.Hepatology (Baltimore, Md.)|April 1, 1991
Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivoL Rossaro, V Mazzaferro, C L Scotti-Foglieni, et al.Transplantation Proceedings|February 1, 1987
OKT3 in the reversal of acute hepatic allograft rejectionC O Esquivel, J J Fung, B Markus, et al.Gastroenterology|December 1, 1987
Rapid growth of an intact human liver transplanted into a recipient larger than the donorD H Van Thiel, J S Gavaler, I Kam, et al.Journal of the American College of Surgeons|November 14, 1997
Hepatic resection and transplantation for peripheral cholangiocarcinomaF A Casavilla, J W Marsh, S Iwatsuki, et al.Transplantation|May 1, 1992
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patientsA J Demetris, J J Fung, S Todo, et al.Pageof 72